Management of Overactive Bladder: Defining the Role of Extended-Release Tolterodine

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.12, Iss.2, 2004-01, pp. : 121-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-release opioids for the management of chronic non-malignant pain

By Sloan Paul Babul Najib

Expert Opinion on Drug Delivery, Vol. 3, Iss. 4, 2006-07 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Management of Erectile Dysfunction: Defining the Role of Sildenafil

By Lyseng-Williamson K.A. Wagstaff A.J.

Disease Management & Health Outcomes, Vol. 10, Iss. 7, 2002-01 ,pp. : 431-452

Adis International

Access to resources Recommend Favorite

Management of Community-Acquired Pneumonia: Defining the Role of Azithromycin

By Gunasekara N.S. Barman Balfour J.A.

Disease Management & Health Outcomes, Vol. 5, Iss. 1, 1999-01 ,pp. : 41-54

Adis International

Access to resources Recommend Favorite

Management of Advanced Breast Cancer: Defining the Role of Toremifene

By Holliday S.M. Faulds D.

Disease Management & Health Outcomes, Vol. 3, Iss. 3, 1998-03 ,pp. : 143-152

Adis International

Access to resources Recommend Favorite

Management of Rheumatoid Arthritis: Defining the Role of Etanercept

By Keating G.M. Jarvis B.

Disease Management & Health Outcomes, Vol. 10, Iss. 1, 2002-01 ,pp. : 17-39

Adis International

Access to resources Recommend Favorite